Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs12035735
rs12035735
LRRC8D
0.700 GeneticVariation GWASCAT NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study. 29923122

2018
dbSNP: rs10419226
rs10419226
CRTC1
A 0.700 GeneticVariation GWASCAT A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. 24121790

2013
dbSNP: rs11789015
rs11789015
BARX1
A 0.700 GeneticVariation GWASCAT A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. 24121790

2013
dbSNP: rs2178146
rs2178146 		A 0.700 GeneticVariation GWASCAT A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. 24121790

2013
dbSNP: rs2687201
rs2687201 		T 0.700 GeneticVariation GWASCAT A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. 24121790

2013
dbSNP: rs3784262
rs3784262
ALDH1A2
A 0.700 GeneticVariation GWASCAT A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. 24121790

2013
dbSNP: rs4800353
rs4800353 		T 0.700 GeneticVariation GWASCAT A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. 24121790

2013
dbSNP: rs7632500
rs7632500
LOC107986152
C 0.700 GeneticVariation GWASCAT A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. 24121790

2013
dbSNP: rs12203582
rs12203582
IL17F
0.010 GeneticVariation BEFREE We searched electronic databases (PubMed, Embase, Web of Science, CBM and CNKI) to identify papers, published before October 2014, on associations between polymorphisms in the IL-17 pathway genes (rs2275913, rs763780, rs3748067, rs3819025, rs9382084, rs12203582 and rs8193036) and the risk of gastrointestinal diseases. 26164762

2015
dbSNP: rs2275913
rs2275913
IL17A
0.010 GeneticVariation BEFREE Of them, IL-17 (-197G/A) polymorphism (rs2275913) was statistically significantly associated with risk of gastrointestinal diseases, especially for gastrointestinal malignancy and gastroduodenal diseases. 26164762

2015
dbSNP: rs763780
rs763780
IL17F
0.010 GeneticVariation BEFREE However, IL-17 (7488T/C) polymorphism (rs763780) did not show significant associations with gastrointestinal diseases either individually or overall (P>0.05). 26164762

2015
dbSNP: rs8193036
rs8193036
IL17A
0.010 GeneticVariation BEFREE We searched electronic databases (PubMed, Embase, Web of Science, CBM and CNKI) to identify papers, published before October 2014, on associations between polymorphisms in the IL-17 pathway genes (rs2275913, rs763780, rs3748067, rs3819025, rs9382084, rs12203582 and rs8193036) and the risk of gastrointestinal diseases. 26164762

2015
dbSNP: rs1801282
rs1801282
PPARG
0.010 GeneticVariation BEFREE One hundred and fifty-five patients with upper gastrointestinal diseases (76 peptic ulcer and 79 non-cardia gastric cancer) and 152 matched controls were genotyped for PPAR-γ gene polymorphism (Pro12Ala) by the PCR-RFLP method. 20568969

2010
dbSNP: rs1805192
rs1805192
PPARG
0.010 GeneticVariation BEFREE One hundred and fifty-five patients with upper gastrointestinal diseases (76 peptic ulcer and 79 non-cardia gastric cancer) and 152 matched controls were genotyped for PPAR-γ gene polymorphism (Pro12Ala) by the PCR-RFLP method. 20568969

2010